Digital Autopsy is pioneered by iGene, a company founded in Malaysia that specialises in the development of Advanced Medical Visualisation Technology worldwide - greatly benefitting the fields of forensics, life sciences, R&D and medical education.

Since the early 2000s, iGene has worked to develop its Digital Autopsy software. This latest development represents a compassionate step forward in establishing a cause of death.

During its journey, iGene has won numerous awards and been cited by international journals for its pioneering work. iGene’s UK investment has even received praise from HRH Duke of Edinburgh & Prime Minister David Cameron.

Funded entirely by iGene, each Digital Autopsy Facility
 is staffed by a team of highly skilled pathologists & radiologists. iGene remains committed to opening further centres, its ambition being to ensure that Digital Autopsy is available to residents throughout England & Wales.

In addition to its groundbreaking use of digital imaging in post-mortem, iGene’s portfolio of innovative products & services also includes:

Crime Scene Investigation
iGene’s Crime Scene Investigation (iCSI) Toolbox is a digital solution that provides 360º panoramas and 3D measurement features, delivering an easier way to reconstruct a crime scene through photos, with unparalleled features for crime scene investigators.

XHUM3D® is a web-based tool that allows medical students, practitioners and teachers to explore human anatomy. It is a fresh approach in teaching intricate details of human anatomy and system physiology, using computer-imaging technologies to create a ‘Digital Cadaver’ which can be repeatedly ‘dissected’, explored and accessed worldwide.

Veterinary Imaging
The EQUIVIZ® veterinary imaging facility allows veterinarians to make more accurate diagnoses, and assists the Equine Competition fraternity in efficiently managing horses in a quantitative and visual manner.


For more information on iGene, please contact us or visit

"Together we are innovators, worldwide leaders in developing technologies that will greatly benefit the fields of forensics, life sciences, R&D and medical education."

Matt Chandran
Chief Executive Officer
iGene Global